Concepedia

Author

C. Bokemeyer

Medizinische Hochschule Hannover

Also Known As

C Bokemeyer, C. BOKEMEYER, C. Bokemeyer, C.  Bokemeyer, C., Bokemeyer, C.P. Bokemeyer, F. Langer

164

Publications

1.5K

Citations

20

H-Index

59

Concepts

All Affiliations

Medizinische Hochschule HannoverUniversität HamburgUniversity Medical Center Hamburg-EppendorfUniversity of TübingenWilhelminen Hospital
CB

About

C. Bokemeyer is an author at Medizinische Hochschule Hannover specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

19

525

2

Health Sciences

7

7

288

3

Blood Transplantation

1

1

37

4

Cellular Therapies

1

1

37

5

Diagnostic Sciences

1

1

37

C. Bokemeyer

×

27

Publications

889

Citations

17

H-Index

YearCitations

Incidence of Metachronous Testicular Cancer in Patients With Extragonadal Germ Cell Tumors

J. T. Hartmann, S.D. Fosså, Craig R. Nichols,

JNCI Journal of the National Cancer Institute

2001

162

Cetuximab plus 5-FU/FA/oxaliplatin (FOLFOX-4) versus FOLFOX-4 in the first-line treatment of metastatic colorectal cancer (mCRC): OPUS, a randomized phase II study

C. Bokemeyer, Igor Bondarenko, J.T. Hartmann,

Journal of Clinical Oncology

2007

101

Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials

C. Bokemeyer, Christian Kollmannsberger, Sally Stenning,

British Journal of Cancer

2004

100

Cisplatin nephrotoxicity and protection by silibinin

J. Gaedeke, L. M. Fels, C. Bokemeyer,

Nephrology Dialysis Transplantation

1996

65

A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia

H Ludwig, Matti Aapro, C. Bokemeyer,

Supportive Care in Cancer

2014

37

Long term follow up in relapsed Hodgkin’s disease (HD): Updated results of the HD-R1 study comparing conventional chemotherapy (cCT) to high-dose chemotherapy (HDCT) with autologous haemopoetic stem cell transplantation (ASCT) of the German Hodgkin Study Group (GHSG) and the Working Party Lymphoma of the European Group for Blood and Marrow Transplantation (EBMT)

Norbert Schmitz, Heinz Haverkamp, Andreas Josting,

Journal of Clinical Oncology

2005

37

Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer

M. Kuczyk, C. Bokemeyer, Julia Hartmann,

Oncology Reports

2001

34

Interaction between <i>Helicobacter pylori and </i>Human Gastric Epithelial Cells in Culture: Effect of Antiulcer Drugs

Siegfried Wagner, Winfried Beil, sup U.E.H. sup Mai,

Pharmacology

1994

33

3004 ORAL Cetuximab plus 5-FU/FA/oxaliplatin (FOLFOX-4) in the first-line treatment of metastastic colorectal cancer (mCRC): a large-scale phase II study, OPUS

C. Bokemeyer, Anatoly Makhson, Igor Bondarenko,

European Journal of Cancer Supplements

2007

27

A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours

C. Bokemeyer, Hans‐Joachim Schmoll, A. Harstrick,

European Journal of Cancer

1993

26

Page 1